RARA CRAFT DATABASE for FDA Medical Devices
510(k)K253593

FDA DEVICE FACTS

Clarius Ejection Fraction AI

Clarius Mobile Health Corp.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

AI/MLPCCP: Authorized
DECISION DATEMarch 2, 2026PRODUCT CODEQIHCLINICAL AREARadiology

Indications for use

Clarius Ejection Fraction AI is intended for semi-automatic non-invasive measurement of the left ventricular ejection fraction on ultrasound data acquired by the Clarius Ultrasound Scanner (i.e., phased array and curvilinear scanners). The user shall be a healthcare professional trained and qualified in ultrasound. The user retains the responsibility of confirming the validity of the measurements based on standard practices and clinical judgment. Clarius Ejection Fraction AI is intended for use in adult patients only. Prescription Use.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 22, 2026